165 related articles for article (PubMed ID: 10433156)
1. Suppression of N(epsilon)-(carboxymethyl)lysine generation by the antioxidant N-acetylcysteine.
Nakayama M; Izumi G; Nemoto Y; Shibata K; Hasegawa T; Numata M; Wang K; Kawaguchi Y; Hosoya T
Perit Dial Int; 1999; 19(3):207-10. PubMed ID: 10433156
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo generation and kinetics of glycosylation products in peritoneal dialysis effluents.
Yokota S; Kumano K; Hyodo T; Sakai T; Izumi G; Hashimoto A; Shibata K; Wang H
Adv Perit Dial; 1998; 14():195-9. PubMed ID: 10649723
[TBL] [Abstract][Full Text] [Related]
3. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
[TBL] [Abstract][Full Text] [Related]
4. In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis.
Tauer A; Knerr T; Niwa T; Schaub TP; Lage C; Passlick-Deetjen J; Pischetsrieder M
Biochem Biophys Res Commun; 2001 Feb; 280(5):1408-14. PubMed ID: 11162688
[TBL] [Abstract][Full Text] [Related]
5. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
[TBL] [Abstract][Full Text] [Related]
6. Influence of icodextrin on plasma and dialysate levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine.
Konings CJ; Schalkwijk CG; van der Sande FM; Leunissen KM; Kooman JP
Perit Dial Int; 2005; 25(6):591-5. PubMed ID: 16411527
[TBL] [Abstract][Full Text] [Related]
7. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
[TBL] [Abstract][Full Text] [Related]
8. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
[TBL] [Abstract][Full Text] [Related]
9. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
10. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of furosine and pentosidine in CAPD patients.
Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
[TBL] [Abstract][Full Text] [Related]
12. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
13. Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
Iijima K; Fujimoto D; Irie S
Connect Tissue Res; 2007; 48(5):271-6. PubMed ID: 17882703
[TBL] [Abstract][Full Text] [Related]
14. N-Acetyl Cysteine Attenuated the Deleterious Effects of Advanced Glycation End-Products on the Kidney of Non-Diabetic Rats.
Thieme K; Da Silva KS; Fabre NT; Catanozi S; Monteiro MB; Santos-Bezerra DP; Costa-Pessoa JM; Oliveira-Souza M; Machado UF; Passarelli M; Correa-Giannella ML
Cell Physiol Biochem; 2016; 40(3-4):608-620. PubMed ID: 27898405
[TBL] [Abstract][Full Text] [Related]
15. Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry.
Miki Hayashi C; Nagai R; Miyazaki K; Hayase F; Araki T; Ono T; Horiuchi S
Lab Invest; 2002 Jun; 82(6):795-808. PubMed ID: 12065691
[TBL] [Abstract][Full Text] [Related]
16. Phytochemical-Rich Antioxidant Extracts of Vaccinium Vitis-idaea L. Leaves Inhibit the Formation of Toxic Maillard Reaction Products in Food Models.
Račkauskienė I; Pukalskas A; Fiore A; Troise AD; Venskutonis PR
J Food Sci; 2019 Dec; 84(12):3494-3503. PubMed ID: 31737914
[TBL] [Abstract][Full Text] [Related]
17. Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium.
LeWinter MM; Taatjes D; Ashikaga T; Palmer B; Bishop N; VanBuren P; Bell S; Donaldson C; Meyer M; Margulies KB; Redfield M; Bull DA; Zile M
Physiol Rep; 2017 Nov; 5(20):. PubMed ID: 29066596
[TBL] [Abstract][Full Text] [Related]
18. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.
Reber F; Geffarth R; Kasper M; Reichenbach A; Schleicher ED; Siegner A; Funk RH
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):213-25. PubMed ID: 12644946
[TBL] [Abstract][Full Text] [Related]
19. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
Ikeda K; Higashi T; Sano H; Jinnouchi Y; Yoshida M; Araki T; Ueda S; Horiuchi S
Biochemistry; 1996 Jun; 35(24):8075-83. PubMed ID: 8672512
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
Shibayama R; Araki N; Nagai R; Horiuchi S
Diabetes; 1999 Sep; 48(9):1842-9. PubMed ID: 10480617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
